Related by context. All words. (Click for frequent words.) 76 Orphan Medicinal Product 75 orphan medicinal product 74 orphan drug 74 Orphan Drug status 71 Orphan Drug designations 71 orphan designation 71 Orphan Drug Designation 70 FDA Orphan Drug 70 Orphan Drug designation 68 granted orphan medicinal 67 Orphan Status 66 granted Orphan Drug 66 TEMODAL 66 Orphan Drug Status 66 Orphan Designation 66 Orphan designation 66 Granted Orphan Drug 65 granted orphan 65 Fast Track Designation 65 Li Fraumeni Syndrome 65 Vandetanib 65 Fast Track Status 64 Panzem R 64 Yondelis ® 64 Lambert Eaton Myasthenic 64 Syndrome LEMS 63 Orphan medicinal 63 Pirfenidone 63 Receives Orphan Drug Designation 63 Carfilzomib 63 Orphan Drugs 63 Amrubicin 63 Campath ® 62 ADVEXIN 62 Etanercept 62 Nimotuzumab 62 Elesclomol 62 OMP designation 62 Lubiprostone 62 Nexavar ® 62 Aviptadil 62 Zenpep 62 Peginterferon alfa 2b 62 refractory Hodgkin lymphoma 62 Fast Track designations 62 Cellegesic 62 Ofatumumab 61 severe gastroparesis 61 histone deacetylase HDAC inhibitor 61 Receives Marketing Authorization 61 methylnaltrexone bromide 61 Lenalidomide 61 LHRH antagonist 61 Clofarabine 61 Pixantrone 61 Receives Orphan Drug 61 OMAPRO ™ 61 Archexin 61 BYETTA ® 61 Oncology Drug 61 Evoltra ® 61 PEGylated anti 61 Eculizumab 61 topical NSAID 61 novel oral anticoagulant 61 Investigational Treatment 61 Belimumab 61 proteasome inhibitor 61 Eprodisate KIACTA TM 61 sorafenib tablets 61 RhuDex ® 61 Soliris TM eculizumab 61 FDA Accepts 61 mitogen activated ERK kinase 61 Everolimus 61 Pralatrexate 61 targeted radiotherapeutic 61 anticancer compound 61 Fast Track designation 61 FRDA 61 oncology indications 61 Advexin 60 Raptiva R 60 Clevudine 60 Myelodysplastic Syndromes 60 IgG1 monoclonal antibody 60 RNAi Therapeutic 60 investigational humanized monoclonal antibody 60 TNF Tumor Necrosis Factor 60 Trobalt 60 PNP inhibitor 60 Noxafil 60 Aryplase 60 Torisel 60 Liprotamase 60 mTOR inhibitor 60 Proxinium TM 60 Files IND 60 Vidaza azacitidine 60 Perifosine 60 SNT MC# 60 Fibrillex TM 60 Pathway Inhibitor 60 PGL# 60 Romiplostim 60 Icatibant 60 Tostrex 60 Dapagliflozin 60 small molecule Hedgehog 60 Ambrisentan 60 Priority Review 60 Onconase 60 XYOTAX TM 60 Advanced Renal Cell 60 Marketing Authorization 60 XIAPEX ® 60 DORIBAX 60 TYZEKA 60 pseudobulbar affect PBA 60 Hsp# Inhibitor 60 orally administered inhibitor 60 Grants Orphan Drug 60 refractory chronic lymphocytic 60 Receives Fast Track 60 Bevacizumab 60 Silodosin 60 Xyrem ® 60 relapsing multiple sclerosis 60 Ceflatonin 60 Marketing Authorization Application 60 SYCREST 60 Raptiva ® 59 Evoltra 59 PEGylated Fab fragment 59 Traficet EN 59 Medidur ™ FA 59 Actemra tocilizumab 59 recurrent refractory 59 Voreloxin 59 Plenaxis R 59 CEQ# 59 BENLYSTA ® 59 Preotact R 59 LUVENIQ 59 investigational pharmacologically unique 59 Clolar ® 59 Tasigna nilotinib 59 Ridaforolimus 59 oropharyngeal candidiasis 59 gastrointestinal stromal tumors 59 Pegloticase 59 AA amyloidosis 59 Kuvan R 59 Bayer Nexavar 59 Cx# [002] 59 Positive Opinion 59 Collategene 59 Iluvien ® 59 Orphan Products 59 Investigational Drug 59 Taliglucerase alfa 59 Sycrest 59 Safinamide 59 GTC recombinant form 59 ixabepilone 59 receptor tyrosine kinase inhibitor 59 Vicinium TM 59 Tamibarotene 59 Marketing Authorisation Application 59 ASP# 59 Golimumab 59 Pfizer Sutent 59 GW# [003] 59 ATryn ® 59 Arzerra ofatumumab 59 MPS VI 59 Certican 59 ADP receptor antagonist 59 Anti TNF 59 Ciclesonide 59 Prolongs Survival 59 Bazedoxifene 59 Tetrabenazine 59 ALN TTR 59 Hepatocellular Carcinoma 59 Tyrosine Kinase Inhibitor 59 Fabry Disease 59 humanized monoclonal antibody 59 biologic therapy 59 Irinotecan 59 Glybera R 59 SUTENT ® 59 XIAFLEX ™ 59 solifenacin succinate 59 hypereosinophilic syndrome 59 Application MAA 59 Familial Adenomatous Polyposis FAP 59 docetaxel Taxotere ® 59 Rivaroxaban 59 Civacir 59 Accelerated Approval 59 Humira adalimumab 59 #D#C# 59 Thalidomide Pharmion 59 topically applied SEPA 59 Gamunex C 59 Oral Spray 59 Ceftobiprole 59 Advagraf 59 acyclovir Lauriad R 59 investigational 59 Cutaneous T 59 Troxatyl 59 Dupuytren Contracture 58 PDE4 inhibitor 58 radiation sensitizer 58 targeted antifolate 58 Psoriasis Drug 58 sapropterin dihydrochloride 58 Bafetinib 58 Dupuytren contracture 58 TORISEL TM 58 relapsed leukemia 58 Junovan 58 erlotinib Tarceva ® 58 mertansine 58 Meets Primary Endpoint 58 YONDELIS 58 histamine dihydrochloride 58 Friedreich Ataxia FRDA 58 Tarceva TM 58 Pivotal Phase III 58 Initiate Clinical Trial 58 Firazyr 58 markets Gelclair R 58 Luveniq 58 Investigational Compound 58 Pafuramidine 58 Methylnaltrexone 58 MGCD# [001] 58 ThermoDox R 58 mild vasodilator 58 HuMax CD4 58 Preotact 58 Phenoptin 58 Genasense ® 58 Glatiramer Acetate 58 Inhalation Aerosol 58 Mepact 58 ORENCIA R 58 NOXAFIL 58 Zorbtive TM 58 Mimpara 58 HDAC Inhibitor 58 RANK Ligand inhibitor 58 diarrhea predominant irritable 58 Kit CD# positive 58 GTC recombinant human 58 efalizumab 58 Ranolazine 58 Cetrorelix 58 Sorafenib 58 orphan medicinal 58 Australian Therapeutic Goods 58 cutaneous T 58 alvimopan 58 Daclizumab 58 R lenalidomide 58 Chronic Lymphocytic Leukemia 58 ALVESCO R 58 somatostatin analogue 58 lymphoid malignancies 58 Kepivance 58 directed radiotherapeutic antibody 58 Vitrasert R 58 Angiox R 58 Cladribine 58 ZEFTERA TM Zevtera TM 58 molecular imaging radiopharmaceutical 58 Gleevec Glivec 58 UPLYSO 58 Saxagliptin 58 Tolvaptan 58 LymphoStat B belimumab 58 Inhalation Solution 58 opioid induced constipation OIC 58 amifampridine phosphate 58 Gefitinib 58 Zolinza 58 Idiopathic Pulmonary Fibrosis 58 Medicinal Products EMEA 58 Pemetrexed 58 Velcade bortezomib 58 ZOLINZA 58 rheumatoid arthritis psoriatic arthritis 58 Aflibercept 58 Cladribine Tablets 58 liver resection surgeries 58 Apaziquone 58 vemurafenib 58 pancreatic enzyme replacement 58 TORISEL 58 Esbriet ® 58 investigational antiplatelet agent 58 cutaneous T cell 58 Cimzia certolizumab pegol 58 JAK2 Inhibitor 58 STELARA TM 58 Expanded Indication 58 Augment TM 58 Genasense R 58 Rilonacept 58 EOquin 58 Silenor ® 58 Maribavir 58 Epratuzumab 58 Phase III Clinical Trial 58 BEMA Fentanyl 58 volociximab 58 rilonacept 58 Remicade infliximab 58 Arimoclomol 58 chimeric monoclonal antibody 58 Product Designation 58 Tanespimycin 58 Hycamtin 58 Hexvix ® 58 Certolizumab pegol 58 oral prodrug 58 Febuxostat 58 ATL# [002] 58 Tocilizumab 58 Factor VIIa 58 PrevOnco 58 Sapacitabine 58 Clolar 58 Dasatinib 58 Onco TCS 58 cinacalcet HCl 58 Receives Positive Opinion 58 Solzira TM 57 investigational compound 57 Rituxan rituximab 57 Loramyc R 57 Immunosuppressant 57 Teysuno 57 alefacept 57 MabCampath 57 ankylosing spondylitis psoriatic arthritis 57 Fondaparinux 57 Melphalan 57 GI GVHD 57 Chemokine Receptor 57 eprodisate Fibrillex TM 57 Sanvar R 57 Zarnestra 57 myelodysplastic myeloproliferative diseases 57 dasatinib Sprycel ® 57 Sebivo 57 BAY #-# 57 thalidomide Thalomid 57 Onalta 57 metastatic gastric 57 class mGluR5 inhibitor 57 generation purine nucleoside 57 Alitretinoin 57 Drug Eluting Stent System 57 Aplidin 57 Bendamustine 57 Rectogesic 57 oral dual endothelin 57 Development OOPD 57 pulmonary arterial hypertension PAH 57 Alemtuzumab 57 pediatric Crohn disease 57 Modrenal R 57 Simulect 57 Myelodysplastic Syndrome 57 NEBIDO R 57 Ixempra 57 cell lymphoma CTCL 57 Silenor ® doxepin 57 Lodotra 57 refractory acute promyelocytic 57 Increlex R 57 selective modulator 57 GATTEX TM 57 Monoclonal Antibody 57 Keppra ® levetiracetam 57 Phase 2a Clinical Trial 57 equine osteoarthritis 57 selective A2A adenosine receptor 57 Fluconazole 57 submitted Marketing Authorization 57 Phase 2b Clinical Trial 57 essential thrombocythemia ET 57 vapreotide acetate 57 oral anticoagulant 57 REBETOL combination therapy 57 treat chronic sinusitis 57 IRESSA 57 RELISTOR ® 57 investigational therapies 57 autologous cellular immunotherapy 57 LUCASSIN 57 Allovectin 7 ® 57 Ceflatonin ® 57 Bucindolol 57 Aliskiren 57 Complicated Skin 57 RoActemra 57 anticancer agent 57 thetreatment 57 Satraplatin 57 Zebinix 57 KNS # 57 Tibotec Therapeutics division 57 GVAX Pancreas Vaccine 57 ANYARA 57 Dalbavancin 57 Drug Candidate 57 IL# PE#QQR 57 YONDELIS R 57 Mipomersen 57 MOVIPREP R 57 Phase #b/#a clinical 57 metastatic colorectal 57 ThermoDox ® 57 Metastatic Colorectal Cancer 57 Pulmonary Arterial Hypertension 57 Oral Mucositis 57 Avastin bevacizumab 57 clofarabine 57 European Medicines Evaluation 57 product BioThrax ® 57 Patent Covering 57 Adjuvant Treatment 57 Telavancin 57 RoACTEMRA 57 LEVADEX TM 57 Evoltra R 57 Fingolimod 57 oral proteasome inhibitor 57 Tofacitinib 57 R adalimumab 57 multi kinase inhibitor 57 seliciclib CYC# 57 R sorafenib tablets 57 Phase IIb Trial 57 eltrombopag 57 radiotherapeutic 57 hyaluronidase enzyme 57 systemic fungal infections 57 Alvesco R 57 VIVITROL ® 57 peripherally acting 57 malignant ascites 57 Interferon alpha 57 metastatic malignant 57 investigational oral inhibitor 57 delivers fluocinolone acetonide FA 57 Gaucher Disease 57 RAPAFLO 57 drug ISA# 57 Uvidem 57 Brilique 57 FOLOTYN ® 57 Ceflatonin R 57 Zebinix R 57 HepaSphere 57 Antitumor 57 Vasovist 57 reslizumab 57 HuMax EGFr 57 Herceptin trastuzumab 57 acetonide FA 57 OPAXIO 57 IAP inhibitor 57 Bezielle 57 Fibrin Pad 57 vitreoretinal disorders 57 Milnacipran 57 Frova ® 57 ONSOLIS 56 Talabostat 56 paroxysmal nocturnal hemoglobinuria PNH 56 Hematological Malignancies 56 Bayer Onyx 56 DOXIL 56 Nexavar tablets 56 JAK2 inhibitor 56 Initiates Phase III 56 Rapydan 56 AstraZeneca Symbicort 56 pain palliation 56 Somatuline Depot 56 CE Marked 56 modulator SERM 56 ARRY # 56 RhuDex R 56 adalimumab Humira 56 etanercept Enbrel 56 Boceprevir 56 Epidermal Growth Factor Receptor 56 BLP# Liposome Vaccine 56 investigational monoclonal antibody 56 Panzem R NCD 56 cathepsin K inhibitor 56 mGluR2 positive 56 Gencaro 56 Friedreich Ataxia 56 CONBRIZA 56 Personalized Immunotherapy 56 Mitoxantrone 56 5 lipoxygenase inhibitor 56 Maraviroc 56 TEMODAR 56 Ceplene 56 sorafenib Nexavar 56 Ganciclovir 56 MAGE A3 ASCI 56 Ganite R 56 ATryn R 56 TYKERB 56 novel histone deacetylase 56 Soft Tissue Sarcoma 56 FTY# 56 Romidepsin 56 RAPTIVA 56 OMNARIS HFA 56 IMiD 56 ZALBIN 56 Initiates Clinical 56 RhuDex 56 acute peripheral arterial 56 autoimmune indications 56 Ustekinumab 56 6R BH4 56 Retacrit 56 Squalamine 56 tezampanel 56 Tezampanel 56 Indaflex TM 56 denileukin diftitox 56 Cimzia ® certolizumab pegol 56 non alcoholic steatohepatitis 56 Orencia abatacept 56 Cloretazine ® 56 lintuzumab SGN 56 Small Molecule 56 granted Fast Track 56 Roflumilast 56 Temodar ® 56 Recombinant Human 56 Rare Diseases 56 MEK inhibitor 56 Mirapexin 56 Natalizumab 56 herpetic keratitis 56 CDK cyclin dependent 56 ASONEP 56 oxaliplatin Eloxatin 56 BiovaxID TM 56 Atypical Hemolytic Uremic Syndrome 56 acadesine 56 Octreolin 56 humanized anti 56 Ixabepilone 56 Chronic Lymphocytic Leukemia CLL 56 Microplasmin 56 Systemic Sclerosis 56 topically administered 56 Thrombin topical Recombinant 56 Opterone R 56 targeting CD# 56 Allovectin 7 R 56 Tygacil 56 Desvenlafaxine 56 Elagolix 56 Pivotal Trial 56 Topotecan 56 Estrogen Receptor 56 CAMPATH R 56 pregabalin Lyrica 56 Azedra 56 Somatuline R Autogel R 56 silodosin 56 injectable formulation 56 Erwinase 56 idursulfase 56 Signaling Pathway 56 immunotherapeutic vaccine 56 Temsirolimus 56 Fodosine 56 ADVEXIN p# therapy 56 Troxatyl TM 56 lexidronam injection 56 systemic immunosuppressive drugs 56 tamibarotene 56 Marketing Authorisation 56 Combidex 56 Alvesco ® 56 Advanced Melanoma 56 Alferon N 56 Kineret R 56 Prodrug 56 BRILINTA 56 RNAi therapeutic targeting 56 ENTEREG ® 56 Abstral 56 Eribulin 56 Zelrix 56 Mycamine 56 NDA Submission 56 Exelixis XL# 56 Long Term Efficacy 56 homozygous FH 56 ONCASPAR 56 Omalizumab 56 serotonin norepinephrine reuptake inhibitor 56 apaziquone 56 label Lipofen R 56 XIAFLEX ® 56 MKC# MKC# PP 56 secondary hyperparathyroidism 56 Files Investigational 56 R Saizen R 56 Doripenem 56 gastrointestinal disorders characterized 56 depsipeptide 56 Intravenous Human 56 Serdolect ® 56 Initiates Clinical Trial 56 Efficacy Trial 56 Phase III Trial 56 Serostim ® 56 Campath alemtuzumab 56 Pazopanib 56 Ocrelizumab 56 IMiDs ® compound 56 diabetic neuropathic pain 56 Prodarsan R 56 Granulocyte Colony Stimulating Factor 56 Rheumatoid Arthritis 56 FUSILEV ® 56 rasagiline tablets 56 fosbretabulin 56 Rifaximin 56 UCB Cimzia 56 imatinib Gleevec ® 56 ARG# 56 FIRMAGON R 56 HQK 56 Omacetaxine 56 Revolade 56 Dacogen injection 56 Bortezomib 56 Application BLA 56 NPC 1C 56 DexaSite 56 Myelodysplastic Syndromes MDS 56 sodium glucose cotransporter 56 Peramivir 56 prokinetic agent 56 BioDelivery Sciences Announces 56 FIRAZYR 56 Chronic Idiopathic Constipation 55 Onrigin 55 histone deacetylase inhibitor 55 PDX pralatrexate 55 Argatroban 55 ANTEGREN 55 Degarelix 55 Hematologic 55 AMITIZA R 55 Therapy Evaluation 55 Anaplastic 55 Etravirine 55 peripheral neuropathic pain 55 Arixtra 55 MORAb 55 Cancidas 55 Emend 55 TG# [003] 55 post operative ileus 55 MTP inhibitor 55 hormone LHRH antagonist 55 Demonstrates Efficacy 55 Allergic Rhinitis 55 Voraxaze 55 Neulasta ® 55 ATryn ® GTC recombinant 55 include Phenoptin TM 55 opioid receptor antagonist 55 BENLYSTA 55 post menopausal osteoporosis 55 ZEVALIN ® 55 relapsing forms 55 TheraCIM 55 Horizant ™ 55 BCR ABL inhibitor 55 Pradefovir 55 antibody MAb 55 Darunavir 55 Zingo TM 55 CryoSeal FS System 55 candidate TNFerade biologic 55 ATG Fresenius S 55 Diamyd ® 55 Vascular Disrupting Agent 55 Oracea ® 55 familial amyloidotic polyneuropathy FAP 55 sublingual tablets 55 forodesine hydrochloride 55 Mylan Receives Approval 55 ospemifene 55 Intravenous CP 55 neovascular age 55 Tesamorelin 55 TYGACIL 55 intravesical infusion therapy 55 Allovectin 7 55 Metastatic Melanoma 55 AVASTIN 55 VISICOL R 55 albinterferon alfa 2b 55 Angiox 55 Taiho Pharmaceutical 55 antiplatelet agent 55 diabetic gastroparesis 55 ezogabine 55 induced macular edema 55 DC Bead 55 fluoroquinolone antibiotic 55 JAK inhibitor 55 Esbriet pirfenidone 55 sunitinib malate 55 Qutenza TM 55 immunomodulatory therapy 55 forodesine 55 IMiDs R 55 LUMINATE 55 Aloxi ® 55 Telzir 55 Exelon rivastigmine 55 arterial thrombosis 55 Adenuric R 55 Camptosar ® 55 advanced hepatocellular carcinoma 55 angiogenesis inhibitor 55 Increlex ® 55 GV# [001] 55 Excellarate TM 55 atypical Hemolytic Uremic Syndrome 55 submit Biologics License 55 tiapamil 55 Alogliptin 55 PLK1 SNALP 55 Enzyme Replacement Therapy 55 formerly LymphoStat B 55 Solazed TM 55 ONSOLIS TM 55 SomatoKine 55 Anti Tumor 55 Myelofibrosis 55 Arzerra TM 55 Centralized Procedure 55 INCB# [003] 55 Sprycel dasatinib 55 ELADUR ™ 55 Entocort 55 Tacrolimus 55 Eraxis 55 advanced metastatic renal 55 overactive bladder AA# 55 Gleevec imatinib mesylate 55 Aztreonam 55 Zenvia ™ 55 TELINTRA 55 methylnaltrexone 55 selective kinase inhibitor 55 Sudhir Agrawal D.Phil 55 Afatinib 55 CIMZIA ™ 55 Aplidin R 55 Fx #A 55 Insegia 55 intranasal formulation 55 Movectro 55 Leukine ® 55 Nexavar sorafenib 55 Anturol TM 55 Mantle Cell Lymphoma 55 Rapinyl 55 IMA# 55 SinuNase TM 55 Submits NDA 55 MEK inhibitors 55 gastrointestinal stromal tumors GIST 55 Kuvan TM sapropterin 55 INCB# [001] 55 Vimpat R 55 cinacalcet 55 Lupus Nephritis 55 nasal calcitonin product 55 highly purified pasteurized 55 systemic juvenile idiopathic 55 Cotara R 55 peginesatide 55 Eltrombopag 55 Cimzia ® 55 subependymal giant cell 55 investigational immunotherapy 55 Actemra 55 Albugon 55 TAXUS Element Paclitaxel Eluting 55 Rasagiline 55 HepDirect prodrug 55 Proquin XR 55 PF # [002] 55 post herpetic neuralgia PHN 55 vorinostat 55 Serostim R 55 PrevOnco ™ 55 Naglazyme 55 Lucanix R 55 VALSTAR 55 candidate ridaforolimus 55 Dyloject TM 55 Diabetic Macular Edema 55 multiple myeloma MM 55 ABILIFY ® 55 Severe Sepsis 55 Acute Heart Failure 55 Fidaxomicin 55 Isavuconazole 55 ocular inflammatory 55 Treatment Resistant 55 taliglucerase alfa 55 Zavesca r 55 immunotherapeutic agent 55 Successfully Completes Phase 55 ARIXTRA R 55 Rituximab 55 submitted Biologics License 55 Exalgo TM 55 Progressive Multifocal Leukoencephalopathy 55 Naproxcinod 55 chronic idiopathic thrombocytopenic purpura 55 Functional Dyspepsia 55 atypical antipsychotic medication 55 Anticalin R 55 Firdapse TM amifampridine phosphate 55 Yondelis 55 Acute Myeloid Leukemia AML 55 Dacogen decitabine 55 IND Application 55 Panzem 55 selective adenosine 55 Velaglucerase Alfa 55 GSK# [001] 55 SPL# Gel vaginal microbicide 55 HYCAMTIN 55 Diabetic Nephropathy 55 aripiprazole Abilify 55 CHMP recommendation 55 Nabi HB Intravenous 55 Eligard R 55 AEG# 55 Progenitor Cell 55 ATPace TM 55 Solazed ™ 55 Arranon 55 Adalimumab 55 pancreatic insufficiency 55 Study Evaluating 55 ABILIFY R 55 Major Depressive Disorder MDD 55 Firdapse ™ amifampridine phosphate 55 Gleevec imatinib 55 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 55 use transdermal sumatriptan 55 Lung Cancer Drug 55 polymerase inhibitor 55 OHR/AVR# 55 LEUKINE 55 Elvitegravir 55 Nivestim 55 Immunotherapeutic 55 Vidofludimus 55 beta 1a 55 Phase Ib IIa 55 Alfimeprase 55 ORENCIA ® 55 subcutaneous formulation 55 Generic Version 55 pan HDAC inhibitor 55 Increlex TM 55 Rebif ® 55 STELARA ™ 55 Soliris eculizumab 55 nucleoside analog 55 lubiprostone 55 Loxapine 55 Aurora Kinase 55 Catena ® 55 Trial Evaluating 55 Junovan TM 55 diagnostic molecular imaging 55 BrachySil TM 55 Supplemental Biologics License Application 55 Nuedexta 55 TH# [003] 54 Marketing Authorization Application MAA 54 Expedited Review 54 DepoDur 54 Enzastaurin 54 Urocidin TM 54 Loramyc ® 54 Loramyc 54 PREOS R 54 EVIZON TM 54 Aloxi R 54 OvaRex R 54 Congenital Emphysema 54 prucalopride 54 mGluR5 negative 54 Glioblastoma Multiforme 54 romiplostim 54 metastatic carcinoid 54 Cinacalcet HCl 54 Sodium oxybate 54 Fludara ® 54 Behcet uveitis 54 Paraplatin ® 54 Phase 2a Trial 54 Combination REOLYSIN R 54 Abstral ® 54 KALBITOR ® 54 Vitrasert ® 54 Votrient 54 TAFA# 54 PKC# 54 Lomitapide 54 INSPIRE Trial Phase III 54 Clinical Trial Evaluating 54 OMNARIS Nasal Spray 54 Uplyso 54 Kuvan 54 Virulizin ® 54 Ticagrelor 54 Afinitor ® 54 SURFAXIN 54 Anidulafungin 54 BEMA Buprenorphine 54 Gleevec resistant 54 Ostarine ™ 54 orBec 54 Azacitidine 54 PD LID 54 zolpidem tartrate sublingual tablet 54 Antibody Drug Conjugate 54 ATL# [001] 54 Trovax 54 Valtropin 54 Orapred ODT 54 topical anti infective 54 Laquinimod 54 Jevtana 54 Rescula 54 SJIA 54 VEGF Trap 54 sunitinib Sutent 54 treat GI GVHD 54 Sprycel 54 tocilizumab 54 Arcalyst 54 fibromyalgia syndrome 54 Cetuximab 54 Kinase Inhibitor 54 XIAPEX 54 HCV Protease Inhibitor 54 fluoropyrimidine 54 Acute Myeloid Leukemia 54 PROMACTA 54 Completes Patient Enrollment 54 MAP# 54 TREANDA 54 chemotherapy induced neutropenia 54 allosteric modulator NAM 54 Biosimilar 54 Biologics Licensing 54 VIDAZA 54 ketolide antibiotic 54 TRO# 54 HoFH 54 TRISENOX ® 54 trabectedin 54 Malignant Melanoma